Mission Wealth Management, LP Pfizer Inc Transaction History

Mission Wealth Management, LP

$4.1 Billion
Q3 2024

A detailed history of Mission Wealth Management, LP transactions in Pfizer Inc stock. As of the latest transaction made, Mission Wealth Management, LP holds 71,502 shares of PFE stock, worth $1.91 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

71,502

Previous 67,275 6.28%

Holding current value

$1.91 Million

Previous $1.88 Million 9.94%

% of portfolio

0.05%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$27.7 - $31.39 $117,087 - $132,685	4,227 Added 6.28%	71,502 $2.07 Million
Q2 2024 Aug 02, 2024	SELL	$25.26 - $29.6 $167,195 - $195,922	-6,619 Reduced 8.96%	67,275 $1.88 Million
Q1 2024 Apr 30, 2024	BUY	$25.89 - $29.73 $51,883 - $59,578	2,004 Added 2.79%	73,894 $2.05 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $331,145 - $430,121	-12,673 Reduced 14.99%	71,890 $2.07 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $316,952 - $370,486	-9,877 Reduced 10.46%	84,563 $2.8 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $35,253 - $40,787	976 Added 1.04%	94,440 $3.46 Million
Q1 2023 Apr 07, 2023	SELL	$39.39 - $51.28 $43,407 - $56,510	-1,102 Reduced 1.17%	93,464 $3.81 Million
Q4 2022 Feb 02, 2023	BUY	$41.75 - $54.5 $438,124 - $571,923	10,494 Added 12.48%	94,566 $4.85 Million
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $139,856 - $170,730	3,196 Added 3.95%	84,072 $3.68 Million
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $89,151 - $105,705	1,916 Added 2.43%	80,876 $4.24 Million
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $248,148 - $307,486	5,424 Added 7.38%	78,960 $4.09 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $3,016 - $4,471	-73 Reduced 0.1%	73,536 $4.34 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $307,209 - $394,637	-7,827 Reduced 9.61%	73,609 $3.17 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $73,184 - $82,905	2,038 Added 2.57%	81,436 $3.19 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $251,576 - $283,728	7,512 Added 10.45%	79,398 $2.88 Million
Q4 2020 Jan 19, 2021	SELL	$33.47 - $42.56 $79,625 - $101,250	-2,379 Reduced 3.2%	71,886 $2.65 Million
Q3 2020 Oct 16, 2020	BUY	$31.75 - $37.25 $141,224 - $165,688	4,448 Added 6.37%	74,265 $2.73 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $226,863 - $275,219	7,532 Added 12.09%	69,817 $2.28 Million
Q1 2020 Apr 27, 2020	SELL	$27.03 - $38.62 $54,060 - $77,240	-2,000 Reduced 3.11%	62,285 $2.03 Million
Q1 2020 Apr 10, 2020	SELL	$27.03 - $38.62 $125,148 - $178,810	-4,630 Reduced 6.72%	64,285 $2.1 Million
Q4 2019 Jan 21, 2020	BUY	$32.92 - $37.36 $64,786 - $73,524	1,968 Added 2.94%	68,915 $2.7 Million
Q3 2019 Oct 16, 2019	BUY	$32.49 - $42.13 $126,353 - $163,843	3,889 Added 6.17%	66,947 $2.41 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $25,183 - $28,275	-681 Reduced 1.07%	63,058 $2.73 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $213,637 - $234,716	5,697 Added 9.82%	63,739 $2.71 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $27,352 - $31,184	-711 Reduced 1.21%	58,042 $2.53 Million
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $195,548 - $237,188	-5,673 Reduced 8.81%	58,753 $2.59 Million
Q2 2018 Aug 08, 2018	BUY	$32.98 - $35.16 $222,680 - $237,400	6,752 Added 11.71%	64,426 $2.34 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $149,881 - $173,882	-4,697 Reduced 7.53%	57,674 $2.05 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $919,239 - $975,345	27,638 Added 79.57%	62,371 $2.26 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $45,322 - $49,927	1,462 Added 4.39%	34,733 $1.24 Million
Q2 2017 Aug 11, 2017	BUY	N/A	33,271	33,271 $1.12 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.

Account

Mission Wealth Management, LP Pfizer Inc Transaction History